Child Neurology: Reversible Dementia in an 18-Year-Old Woman Due to Undiagnosed Cobalamin-G Deficiency

Cobalamin-G deficiency is an inborn error of metabolism which disrupts the biochemical utilization of vitamin B12 to covert homocysteine to methionine in the remethylation pathway. Typically, affected patients present within the first year of life with anemia, developmental delay, and metabolic crisis. Few case reports of cobalamin-G deficiency reference a later onset phenotype primarily defined by neuropsychiatric symptoms. We report an 18-year-old woman who presented with a 4-year history of progressively worsening dementia, encephalopathy, epilepsy, and regression of adaptive functioning, with an initially normal metabolic workup. Whole-exome sequencing identified variants in the MTR gene, suspicious for cobalamin-G deficiency. Additional biochemical testing after genetic testing supported this diagnosis. Since treatment with leucovorin, betaine, and B12 injections, we have seen a gradual return to normal cognitive function. This case report expands the phenotypic range of cobalamin-G deficiency and offers rationale for genetic and metabolic testing in cases of dementia in the second decade of life.

[1]  B. Wolf "Think metabolic" in adults with diagnostic challenges: Biotinidase deficiency as a paradigm disorder. , 2017, Neurology. Clinical practice.

[2]  M. Baumgartner,et al.  Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines , 2015, Journal of Inherited Metabolic Disease.

[3]  B. Boeve,et al.  Young-onset dementia: demographic and etiologic characteristics of 235 patients. , 2008, Archives of neurology.

[4]  R. Rosenson,et al.  Preanalytical sources of measurement error: the conundrum of the homocysteine hypothesis. , 2007, Atherosclerosis.

[5]  M. Thall,et al.  Neuropsychiatric Illness in a Patient with Cobalamin G Disease, an Inherited Disorder of Vitamin B12 Metabolism , 2004, Harvard review of psychiatry.

[6]  T. Hudson,et al.  Hyperhomocysteinemia due to methionine synthase deficiency, cblG: structure of the MTR gene, genotype diversity, and recognition of a common mutation, P1173L. , 2002, American journal of human genetics.

[7]  J. R. Simmons,et al.  Reduction of false negative results in screening of newborns for homocystinuria. , 1999, The New England journal of medicine.

[8]  M. Seashore,et al.  Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC) , 1997, Journal of Inherited Metabolic Disease.

[9]  C. Sansaricq,et al.  Newborn screening for homocystinuria. , 1997, Early human development.

[10]  D. Watkins,et al.  Hereditary defect of cobalamin metabolism (cblG mutation) presenting as a neurologic disorder in adulthood. , 1988, The New England journal of medicine.

[11]  D. Watkins,et al.  Genetic heterogeneity among patients with methylcobalamin deficiency. Definition of two complementation groups, cblE and cblG. , 1988, The Journal of clinical investigation.

[12]  D. Watkins,et al.  Vitamin B12 responsive homocystinuria and megaloblastic anemia: heterogeneity in methylcobalamin deficiency. , 1987, American journal of medical genetics.

[13]  Lauren C. Frey,et al.  The Abnormal EEG , 2016 .

[14]  E. Shoubridge,et al.  Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type , 2006, Nature Genetics.

[15]  A. Clark,et al.  Vitamin B12-responsive neonatal megaloblastic anemia and homocystinuria with associated reduced methionine synthase activity. , 1987, Blood.